🔗 Share this article

The prestigious award in Physiology or Medicine was granted for transformative findings that illuminate how the immune system attacks dangerous pathogens while protecting the healthy tissues.

Three esteemed scientists—from Japan Prof. Sakaguchi and American scientists Mary Brunkow and Fred Ramsdell—share this accolade.

The research uncovered specialized "sentinels" within the immune system that eliminate malfunctioning immune cells that could harming the organism.

The discoveries are now enabling innovative treatments for autoimmune diseases and malignancies.

The winners will share a monetary award worth 11m SEK.

Crucial Findings

"The work has been decisive for comprehending how the body's defenses operates and the reason we don't all develop severe self-attack conditions," stated the chair of the Nobel Committee.

This team's studies explain a core question: In what way does the immune system defend us from numerous invaders while leaving our healthy cells unharmed?

The immune system uses immune cells that scan for signs of infection, including viruses and bacteria it has not met before.

These defenders employ detectors—known as receptors—that are generated randomly in countless combinations.

This gives the immune system the ability to combat a broad range of invaders, but the unpredictability of the mechanism unavoidably produces white blood cells that may target the host.

Protectors of the Immune System

Scientists previously knew that a portion of these harmful white blood cells were eliminated in the immune organ—the site where white blood cells mature.

This year's Nobel Prize recognizes the identification of regulatory T-cells—described as the body's "peacekeepers"—which patrol the body to neutralize other defenders that assault the healthy cells.

It is known that this mechanism malfunctions in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee added, "These findings have established a new field of investigation and spurred the creation of innovative therapies, for example for tumors and autoimmune diseases."

In malignancies, T-regs prevent the body from fighting the growth, so studies are aimed at lowering their quantity.

In autoimmune diseases, trials are exploring increasing regulatory T-cells so the organism is not being harmed. A similar method could also be effective in minimizing the chances of transplanted organ rejection.

Innovative Experiments

Prof Shimon Sakaguchi, from a Japanese institution, performed experiments on mice that had their thymus removed, leading to self-attack conditions.

The researcher demonstrated that introducing defense cells from healthy animals could prevent the disease—implying there was a mechanism for blocking immune cells from attacking the body.

Dr. Brunkow, affiliated with the a research center in a US city, and Fred Ramsdell, now at Sonoma Biotherapeutics in a California city, were studying an inherited immune disorder in mice and humans that resulted in the discovery of a genetic factor vital for the way T-regs function.

"The pioneering research has revealed how the body's defenses is kept in check by T-reg cells, preventing it from mistakenly targeting the healthy cells," commented a leading physiology specialist.

"The research is a remarkable illustration of how fundamental biological study can have far-reaching implications for human health."